Medpace Holdings (MEDP)

Medpace Holdings Stock Analysis & Ratings

MEDP Stock Chart & Stats

Day’s Range$137.15 - $143.06
52-Week Range$126.94 - $231.00
Previous Close$140
Average Volume (3M)347.14K
Market Cap$4.62B
P/E Ratio26.1
Next EarningsAug 01, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
Smart Score10
EPS (TTM)5.36



P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.


Risk Analysis

Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Medpace Holdings’s price range in the past 12 months?
Medpace Holdings lowest stock price was $126.94 and its highest was $231.00 in the past 12 months.
    What is Medpace Holdings’s market cap?
    Medpace Holdings’s market cap is $4.62B.
      What is Medpace Holdings’s price target?
      The average price target for Medpace Holdings is $160.00. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is $175.00 ,the lowest forecast is $145.00. The average price target represents 16.58% Increase from the current price of $137.24.
        What do analysts say about Medpace Holdings?
        Medpace Holdings’s analyst rating consensus is a ‘Hold. This is based on the ratings of 2 Wall Streets Analysts.
          When is Medpace Holdings’s upcoming earnings report date?
          Medpace Holdings’s upcoming earnings report date is Aug 01, 2022 which is in 76 days.
            How were Medpace Holdings’s earnings last quarter?
            Medpace Holdings released its earnings results on Apr 25, 2022. The company reported $1.69 earnings per share for the quarter, beating the consensus estimate of $1.26 by $0.43.
              Is Medpace Holdings overvalued?
              According to Wall Street analysts Medpace Holdings’s price is currently Undervalued.
                Does Medpace Holdings pay dividends?
                Medpace Holdings does not currently pay dividends.
                What is Medpace Holdings’s EPS estimate?
                Medpace Holdings’s EPS estimate for its next earnings report is not yet available.
                How many shares outstanding does Medpace Holdings have?
                Medpace Holdings has 33,650,000 shares outstanding.
                  What happened to Medpace Holdings’s price movement after its last earnings report?
                  Medpace Holdings reported an EPS of $1.69 in its last earnings report, beating expectations of $1.26. Following the earnings report the stock price went down -10.405%.
                    Which hedge fund is a major shareholder of Medpace Holdings?
                    Among the largest hedge funds holding Medpace Holdings’s share is Echo Street Capital Management LLC. It holds Medpace Holdings’s shares valued at 114M.


                      Medpace Holdings Stock Analysis

                      Smart Score
                      Price Target
                      ▲(16.58% Upside)
                      The Medpace Holdings stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                      Learn more about TipRanks Smart Score

                      Company Description

                      Medpace Holdings

                      Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in July 1992 and is headquartered in Cincinnati, OH.

                      Similar Stocks
                      Price & Change
                      Syneos Health
                      IQVIA Holdings
                      Vyant Bio
                      Coherus Biosciences

                      Popular Stocks

                      What's Included in PREMIUM?
                      Make informed decisions based on Top Analysts' activity
                      Know what industry insiders are buying
                      Get actionable alerts from top Wall Street Analysts
                      Find out before anyone else which stock is going to shoot up
                      Get powerful stock screeners & detailed portfolio analysis